A patient successfully lived for 271 days with a genetically modified pig kidney transplant before transitioning to a human organ transplant.
This medical milestone, reported on September 4, 2026, demonstrates the viability of xenotransplantation as a bridge for patients awaiting human donors.
Researchers are now analyzing the long-term immune response data to refine protocols for future clinical applications of pig-to-human organ procedures.